secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sigyn Therapeutics, Inc. (SIGY)
CIK:        0001642159
Form:       8-K
Filed at:   2024-01-11T23:59:59+00:00
Accession:  0001493152-24-002048
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sigyn Therapeutics enters share surrender agreement with CTO to cancel 2.56M shares
--------------------------------------------------------------------------------

- Craig Roberts, CTO and board member, surrenders 2,564,000 shares of common stock for cancellation.
- Shares are cancelled and not held as treasury shares; no further claims against the company.
- As of Jan 9, 2024, total outstanding shares are 48,972,602 following this surrender and note conversions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642159/000149315224002048/0001493152-24-002048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642159/000149315224002048/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-002048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer